FOSUN HEALTH Logo

Vestibular Schwannoma Prevention

catalogue

Vestibular Schwannoma Prevention

Vestibular Schwannoma Prevention

A vestibular schwannoma cannot be prevented, and there is no screening test for it. Scanning people without symptoms is not recommended, because the tumour is uncommon and slow-growing and because most tumours announce themselves through the ear anyway. What does exist is a defined surveillance programme for people with the inherited condition neurofibromatosis type 2, a structured way of following a tumour that is being observed, and a written schedule of scans and hearing tests after treatment.

Why there is no screening programme

The question is asked less often here than in other tumours, because this one announces itself — but it is worth answering precisely:

  • The tumour is uncommon in the terms that screening demands, so a programme scanning people without symptoms would examine very many ears to find very few tumours.
  • The symptoms arrive early — a one-sided hearing loss or tinnitus usually appears while the tumour is still small, because the canal leaves no room to spare. The ear is, in effect, the screening test, and the hearing test with an audiogram is the step that follows.
  • No benefit from screening has been demonstrated. For a tumour with this behaviour, no study has shown that finding it before it causes symptoms changes the outcome.
  • What the practical route is — a one-sided, persistent change in hearing or tinnitus deserves a hearing test; asymmetry between the two ears on that test deserves imaging. That pathway finds the tumours that need finding.

Surveillance for the inherited condition

This is the one situation in which imaging is used to look for these tumours before they cause symptoms, because the risk is high enough to justify it:

  • Neurofibromatosis type 2 — an established programme covering both hearing nerves on a schedule, along with the spine and the other nerves the condition can affect, so that tumours are found while they are small and while every option is still open.
  • How it is arranged — under specialist care, with intervals set by the condition rather than by the patient's symptoms, and continued for life because the condition is lifelong.
  • What surveillance is looking for — new tumours and growth of those already known, since treatment decisions in this condition weigh both sides and are made deliberately rather than in a hurry.
  • What to do if you have the diagnosis — follow the schedule set out for you and tell any new clinician about it, because a scan planned for one purpose may not cover the other side or the spine.

What to do about a tumour found by chance

Because these tumours usually announce themselves, the incidental finding is less common here than with some other brain tumours — but it happens, and the handling has become fairly standard:

  • Confirm the diagnosis on the right protocol. A thin-slice contrast MRI through the internal auditory canal, since a routine study may not have covered the canal adequately.
  • Record the hearing. An audiogram on both sides, even when the ear subjectively works, because the baseline is what every later comparison is made against.
  • Decide whether it needs anything now. A small tumour causing nothing is usually observed, with the schedule written down rather than implied.
  • Set the schedule and name what would change it. Growth between scans, a change in the hearing, or new symptoms each move the tumour towards treatment, and those criteria should be stated in advance.
  • Keep one centre holding the images. A comparison cannot be made from a report alone, and the earlier studies are what carry the information.

Symptoms that should be assessed

Because there is no screening programme, the practical substitute is knowing which symptoms warrant assessment rather than a wait-and-see:

  • Hearing loss or ringing in one ear that is new or progressing — the pattern that warrants a hearing test, and imaging if the two ears differ.
  • A feeling of fullness in one ear without wax or infection to explain it, persisting beyond a cold or a sinus episode.
  • A sudden one-sided hearing loss — urgent on its own account, and imaged when the hearing fails to recover.
  • Unsteadiness that is new or worsening, particularly when it comes with a one-sided change in hearing.
  • Numbness or tingling on one side of the face, or weakness of the face, in someone with a known or suspected tumour.
  • Any new symptom in someone under surveillance — reported rather than fitted into the next scheduled scan.

What cannot be done, stated plainly

The avoidable share of the risk is close to nothing, and it is worth describing accurately rather than offering measures without evidence:

  • No diet, supplement or habit changes the risk. No protective measure has been shown to reduce the chance of developing this tumour, and products marketed for that purpose should be treated with caution.
  • Mobile phones do not cause it — no link has been established despite extensive study, so there is nothing to avoid there either.
  • The only exposure that can be limited is unnecessary radiation — the reasonable principle is to avoid examinations that will not change what is done, not to avoid necessary ones.
  • What remains actionable is entirely on the other side of the finding: getting a one-sided symptom assessed properly, keeping the scan schedule, and preserving the hearing and the facial function that exist now.

What follow-up looks like

Follow-up in this condition has a defined structure, and knowing it makes the process manageable:

  • MRI at defined intervals, more frequent in the first period and then widening as the record accumulates, with the schedule given in writing and each scan compared with the previous one.
  • Hearing tests alongside the scans — pure tone and speech discrimination on both sides, since the hearing can change even when the size does not, and the audiogram is the record of what has been preserved.
  • After radiation, the scan is watched for stability over years rather than for an immediate change, and the hearing is watched for the slow drift that radiation can cause.
  • After surgery, the facial function is assessed formally at intervals alongside the imaging, and the hearing is retested to measure what was kept.
  • Balance and tinnitus support continued after the acute phase, since both respond to rehabilitation and neither resolves on a timetable.
  • What to report between scans — new or worsening one-sided hearing change, new facial numbness or weakness, new unsteadiness, or headache that is increasing or waking the patient.

Frequently Asked Questions

Can a vestibular schwannoma be prevented?

No. No intervention has been shown to reduce the chance of developing one, and the factors that are established — the inherited condition neurofibromatosis type 2, previous therapeutic radiotherapy to the head, and adult midlife — are not things a person can change. The attention in this condition goes to what happens after a symptom or a finding appears rather than to preventing it: getting a one-sided change in hearing assessed properly, keeping the scan schedule, and protecting the hearing and the facial function that exist now.

Should I be scanned because a relative had a vestibular schwannoma?

No, in the ordinary case. A single sporadic tumour in a relative is not a hereditary event, and no imaging-based surveillance is recommended for relatives of an ordinary patient. The exception is a family with neurofibromatosis type 2 — a relative with the diagnosis, tumours on both sides, or the other features of the condition — where genetic assessment is appropriate and a defined surveillance programme already exists. A genetics service is the right place to sort out which situation applies, and the conversation is worth having once rather than wondering about it.

What happens with a tumour found by chance?

Most of the time it is observed rather than treated at once. The diagnosis is confirmed with a thin-slice contrast MRI through the canal, the hearing on both sides is recorded as the baseline, and the tumour is followed with scans at defined intervals. What matters practically is that the schedule is written down, that one centre holds the images so that comparisons can be made, and that you know in advance what would change the plan — growth on the scan, a change in the hearing, or a new symptom.

How often will I need scans after treatment?

The schedule is set individually. It is generally more frequent in the first period after treatment and then widens as time passes, and it differs with what was done and with how the tumour behaved. After radiation, the scans are watched for stability over years rather than for an immediate change, and the hearing is tested alongside because a slow drift can occur. The important practical points are that the schedule, with dates, should be given to you in writing, and that a new symptom is a reason to bring the next scan forward rather than to wait for it.

Ask what your follow-up interval should be

Send the MRI images and reports with dates — every scan, not only the latest — the audiograms on both sides, the operative or radiotherapy record if treatment has been given, and the current medication. Our team will return a written assessment within 48 hours of the file being complete, including the follow-up interval appropriate to your tumour.

Want to see the whole process first? Your full medical journey, step by step →

Book an Appointment Request a Video Consultation

Follow Fosun Health

Apply for an Appointment

Do you have test results*